Neurology
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
QUICK SEARCH:   [advanced]


     

This Article
Right arrow Full Text (PDF)
Right arrow Correspondence:
Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when Correspondence are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Bernard, J. T.
Right arrow Articles by Fisher, M.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Bernard, J. T.
Right arrow Articles by Fisher, M.
NEUROLOGY 1990;40:154
© 1990 American Academy of Neurology

Transient focal neurologic deficits complicating interleukin-2 therapy

J. T. Bernard, MD, S. Ameriso, MD, R. A. Kempf, MD, P. Rosen, MD, M. S. Mitchell, MD and M. Fisher, MD

Department of Medicine (Neurology), Cedar Rapids Hospitals, Cedar Rapids, IA.

We report 2 patients with transient, focal, repetitive, stereo-typed episodes of neurologic deficits during treatment with interleukin-2. One patient had recurrent monocular blindness, while the 2nd had recurrent homonymous quadrantanopia. We suggest that these attacks are provoked by endothelial cell activation induced by interleukin-2.

Address correspondence and reprint requests to Dr. Erich W. Streib, Internists P.C., 115 Eighth Street NE, Cedar Rapids, IA 52401.

Supported in part by Teacher-Investigator Development Award K07 NS884 (Dr. Fisher) and ROI NS20989.

Received April 3, 1989. Accepted for publication in final form June 29, 1989.






HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Copyright © 1990 by AAN Enterprises, Inc.